Ubrelvy 100 MG tablet UD 16S
Ended Awarded Last action
- Contract number
- SPE2DR26F6X4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,697
Award facts
- Contract value 100% obligated
- $10,696.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $10,696.66 to AmerisourceBergen Drug Corp for 100 milligram tablets of UBRELVY in unit dose packages of 16 tablets. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The delivery order carries an ultimate completion date of January 21, 2026, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation applies to this award.
UBRELVY (ubrogepant) is a calcitonin gene-related peptide receptor antagonist indicated for acute treatment of migraine in adults. This pharmaceutical delivery aligns with DLA's mission to supply essential medications to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen Drug Corp's status as a critical pharmaceutical vendor demonstrates the company's established capability to fulfill federal procurement requirements for specialized medical products across multiple therapeutic domains, supporting the comprehensive pharmaceutical supply chain for the Department of Defense and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6X4L?
SPE2DR26F6X4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F6X4L worth?
The government has obligated $10,697 on SPE2DR26F6X4L.
Is contract SPE2DR26F6X4L an order under another contract?
Yes. SPE2DR26F6X4L is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6X4L competed?
The extent of competition for SPE2DR26F6X4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award